Insulin is a hormone that is being secreted by the pancreas. The excessive or excessive quantity of insulin into human body may result in disturbance to the human immune system. Diabetes is a chronic disease which is caused either in case if the body is unable to use the insulin pancreas are producing, or no insulin is being secreted at all. Diabetic devices are used to diagnose, monitor and manage type I or type II diabetes diseases. A lot of research and development are undergoing in this sector, which in turn are accounted to be the prime factor for the growth of the market.
South America Diabetes Devices Market Segments Size & Growth:
South America Diabetes Devices Market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% during the forecast timeline 2018-2024. Diabetes devices are used for both monitorings as well as for treatment purposes. As the number of diabetic affected people are increasingly increasing to a larger extent, this market has got wider expansion regarding market forecast and growth. In addition to that increase in the population of obese people, the rise in rapid industrialisation and urbanisation are considered to be the boosting factors for the growth of South America diabetes devices market. Moreover, innovation of new technologies for insulin injection is a primary key factor for the moderate growth of the market throughout the forecast period. However, lack of awareness regarding diabetes, availability for alternative treatments, the high cost of diabetes devices, the disparity in reimbursement, rise in the number of oral drugs and many other factors are considered to be the main challenges for the growth of the overall market of Diabetes Devices in South America.
South America Diabetes Devices Market Segments Share:
The overall growth of the market for Diabetes Devices is considered as the collaboration of individual growths that occurred at various segments of the market. Depending upon the products available, the Diabetic Devices are sectored as a device used for monitoring and devices used for treatments. Various products that are available include, Self-monitoring Blood Glucose Meters, Blood Glucose Testing Strips, Lancets, and Continuous Glucose Monitoring Devices, Insulin Delivery Devices Insulin Syringes, Insulin Pens, and Insulin Pumps, Diabetes Monitoring Software, and Artificial Pancreas System. Depending on the customer’s requirement, a wide variety of pens and pumps are available in the market. Among all, it was accounted previously that the market share was majorly hold Diabetes Monitoring Devices.
Depending upon the distribution channels, the market is segmented as hospital pharmacies, retail pharmacies, online pharmacies, diabetes clinics and centres and many others. Hospital Pharmacies contribute a maximum share to the market of diabetes devices market regarding revenues. Also, increase the number of prescription and non-prescription diabetes care devices, it is estimated that online Pharmacies are also likely to increase throughout the forecast period. Based on the end-users this market is segmented as hospitals, Clinics, Home Healthcare, Ambulatory care and others. Depending on the geographical segmentation, it is expected that the Diabetes Devices Market in South America will be growing at a moderate pace throughout the forecast timeline.
South America Diabetes Devices Market Trends:
- Abbott Completes The Acquisition Of St. Jude Medical
- Ypsomed strengthens its position in the diabetes sector by making a strategic acquisition of ICU Medical; Inc diabetes infusion set business
South America Diabetes Devices Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The major key players in the South America Diabetes Devices Market are:
- Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Acon Laboratories
- Ypsomed AG
- Tandem Diabetes Care, Inc.
- Becton, Dickinson, and Company
- Insulet Corporation
Along with these companies, there were many other companies considered/cited in the report while analysing the South America Diabetes Devices market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in diabetic affected population
4.1.2 Increase in obese population
4.2 Restraints
4.2.1 Availability of alternative treatments
4.2.2 High cost of Diabetic Devices
4.3 Opportunities
4.3.1 growing industrialization and urbanization
4.4 Challenges
4.4.1 lack of awareness among people
4.4.2 Rise in the number of oral drugs
Chapter 5 South America Diabetes Devices Market – By Product
5.1 Glucose Monitoring Devices
5.1.1 Self-Monitoring Blood Glucose meters
5.1.2 Blood Glucose Testing Strips
5.1.3 Lancets
5.1.4 Continuous Glucose Monitoring Devices
5.1.5 Others
5.2 Insulin Delivery Devices
5.2.1 Insulin Syringes
5.2.2 Insulin Pens
5.2.3 Insulin Pumps
5.2.4 Others
5.3 Diabetes Monitoring Software
5.4 Artificial Pancreas System
5.5 Others
Chapter 6 South America Diabetes Devices Market – By Distribution Channels
6.1 Hospitals Pharmacies
6.2 Retail Pharmacies
6.3 Online Pharmacies
6.4 Diabetic Clinics
6.5 Diabetic Centers
6.6 Others
Chapter 7 South America Diabetes Devices Market – By End-Users
7.1 Hospitals
7.2 Clinics
7.3 Home Healthcare
7.4 Ambulatory care
7.5 Others
Chapter 8 South America Diabetes Devices Market – By Geography
8.1 Introduction
8.2 South America
8.2.1 Brazil
8.2.2 Argentina
8.2.3 Others
Chapter 9 South America Diabetes Devices Market – Company Profiles
9.1 Medtronic Public Limited Company
9.2 Novo Nordisk A/S
9.3 Sanofi S.A.
9.4 Eli Lilly and Company
9.5 F. Hoffmann-La Roche Ltd.
9.6 Abbott Laboratories
9.7 Acon Laboratories
9.8 Ypsomed AG
9.9 Tandem Diabetes Care, Inc.
9.10 Becton, Dickinson and Company
9.11 Insulet Corporation
9.12 J&J
Chapter 10 South America Diabetes Devices Market – Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
